Federal government bans chloroform imports in Pakistan, with limited exemptions for pharma firms. Learn why the ban was imposed, policy changes and expected impact.
Chloroform Import Ban Approved by Federal Cabinet
The federal government has reportedly imposed a ban on the import of chloroform in Pakistan, citing serious health and environmental risks associated with the chemical. According to a news report by 24News, the decision was taken after formal approval by the federal cabinet. Following this approval, the Ministry of Commerce issued an official notification to enforce the restriction on chloroform imports across the country.
Chloroform is an industrial and laboratory chemical that has historically been used as a solvent and in certain medical and industrial processes. However, it is also known to pose significant health hazards if inhaled, ingested or handled without proper safeguards. Exposure can affect the liver, kidneys and central nervous system, and long-term or uncontrolled use may contribute to serious illness. These risks, combined with concerns about unsafe handling and possible misuse, have pushed the government to tighten control over the substance.
Amendments to the Import Policy Order 2022
The Ministry of Commerce notification confirms that the ban has been implemented via amendments to the Import Policy Order 2022. Chloroform has now been placed in the category of prohibited imports, meaning that traders and general industrial users can no longer bring the chemical into Pakistan through normal commercial channels. By using the existing import policy framework, the government has effectively created a clear legal basis for customs and regulatory authorities to stop shipments at the border.
Limited Exemptions for Pharmaceutical Manufacturers
Officials have clarified that the decision is not meant to disrupt essential medical and pharmaceutical production. Limited exemptions have therefore been allowed for registered pharmaceutical companies that rely on chloroform as a critical input. Under the new rules, these firms may still import chloroform, but only to meet genuine production requirements and subject to strict documentation and oversight.
To qualify for an exemption, companies must first obtain a No Objection Certificate (NOC) from the Drug Regulatory Authority of Pakistan (DRAP). This condition is intended to ensure that chloroform is imported only by legitimate manufacturers that are properly licensed and monitored. DRAP will be responsible for assessing applications, verifying production needs and ensuring that imported quantities align with approved pharmaceutical uses.
Stronger Oversight, Health Risks and Environmental Concerns
Officials say the move is designed to tighten regulatory oversight and prevent misuse of chloroform, which can cause serious harm if handled improperly or diverted from lawful uses. By restricting imports and routing any essential supplies through a controlled approval process, regulators hope to reduce the risk of accidental exposure, illegal sale or unsafe storage. The measure also aims to bring Pakistan’s chemical safety practices closer to international norms, where hazardous substances are subject to stricter controls.
Environmental concerns have also been highlighted as part of the rationale for the ban. Improper disposal of chloroform and related chemicals can contaminate soil and water, adding to long-term ecological damage. Strengthening controls over such substances is seen as an important step in improving overall environmental governance and reducing the impact of industrial pollution on communities.
What the Ban Means for Industry and Regulation
For industrial users and traders outside the pharmaceutical sector, the prohibition means they will need to review their processes and, where necessary, switch to safer alternative chemicals or technologies. Businesses that previously depended on chloroform-based methods will have to assess the cost and technical implications of this policy shift. In the short term, some adjustment challenges are likely, but regulators argue that the long-term benefits for public health and environmental protection justify the change.
Policy watchers note that the chloroform ban forms part of a wider effort by the government to upgrade chemical safety standards, close regulatory gaps and respond to public health concerns. As more hazardous substances come under review, industries may face tighter reporting and handling requirements. According to 24News, officials believe that proactive measures like this ban are necessary to prevent accidents, misuse and environmental damage before they occur, rather than reacting only after harm has been done.
